Terms: = Ovarian cancer AND PPM1D, Wip1, 8493, ENSG00000170836, O15297, WIP1, PP2C-DELTA AND Prognosis
6 results:
1. MS: wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer.
Yin S; Yang L; Zheng Y; Zang R
J Ovarian Res; 2022 May; 15(1):56. PubMed ID: 35538489
[TBL] [Abstract] [Full Text] [Related]
2. Differential roles of the wip1-p38-p53 DNA damage response pathway in early/advanced-stage ovarian clear cell carcinomas.
Xu C; Minaguchi T; Qi N; Fujieda K; Suto A; Itagaki H; Shikama A; Tasaka N; Akiyama A; Nakao S; Ochi H; Satoh T
World J Surg Oncol; 2022 Apr; 20(1):139. PubMed ID: 35490254
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
Hirata Y; Murai N; Yanaihara N; Saito M; Saito M; Urashima M; Murakami Y; Matsufuji S; Okamoto A
BMC Cancer; 2014 Nov; 14():799. PubMed ID: 25366985
[TBL] [Abstract] [Full Text] [Related]
4. Protein phosphatase magnesium-dependent 1δ (ppm1d) mRNA expression is a prognosis marker for hepatocellular carcinoma.
Li GB; Zhang XL; Yuan L; Jiao QQ; Liu DJ; Liu J
PLoS One; 2013; 8(3):e60775. PubMed ID: 23556002
[TBL] [Abstract] [Full Text] [Related]
5. The estrogen receptor alpha pathway induces oncogenic wip1 phosphatase gene expression.
Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
[TBL] [Abstract] [Full Text] [Related]
6. Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of ppm1d and APPBP2 as likely amplification targets.
Hirasawa A; Saito-Ohara F; Inoue J; Aoki D; Susumu N; Yokoyama T; Nozawa S; Inazawa J; Imoto I
Clin Cancer Res; 2003 Jun; 9(6):1995-2004. PubMed ID: 12796361
[TBL] [Abstract] [Full Text] [Related]
